Matthew Philippe

Matthew Philippe has extensive work experience in the financial industry, focusing primarily on investment analysis and portfolio management in the healthcare sector. Matthew is currently serving as the Executive Vice President at NewAmsterdam Pharma since April 2023. Prior to this role, they worked at Schonfeld as a Portfolio Manager and Managing Director from June 2019 to January 2023. In this role, they were responsible for managing a fundamental equity portfolio focused on global healthcare markets and conducting financial diligence on public and private companies.

Before joining Schonfeld, Matthew worked as an Investment Analyst at Karst Peak Capital from November 2015 to January 2019, where they provided lead coverage of public and private biotechnology, medical devices, pharma, hospitals, supplies, and diagnostics. Matthew'sfocus was on globally traded equities primarily based in Asia.

Matthew also served as a Vice President of Equity Research at Deutsche Bank from July 2014 to November 2015, an Investment Analyst at Avet Capital Management LLC from November 2011 to June 2014, and a Private Equity/Venture Capital Associate at Numoda Capital from July 2009 to July 2011.

Matthew began their career as an Investment Banking Analyst at Collins Stewart from February 2007 to November 2008 and then at Franklin Hamilton from December 2005 to January 2007.

In summary, Matthew Philippe possesses a wealth of experience in investment analysis, portfolio management, and equity research in the healthcare sector.

Matthew Philippe completed their education with an MBA from Columbia Business School, starting in 2011 and finishing in 2013. Prior to this, they pursued a Bachelor of Science and a Bachelor of Arts degree from Colorado State University between 2000 and 2005. Matthew'sareas of study during this period included Finance, Biology, and Spanish.